Gheuens Sarah

Chief Medical OfficerAGIOS PHARMACEUTICALS, INC. (AGIO) · full profile →Form 4 · filed Aug 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$914K
Net Open-Market Flow
-$914K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 4, 2026Sell(S)30K$30.48$914K55K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001439222-26-000120) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.